Related Experiment Video
Updated: May 4, 2026

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Protective role of melatonin in neonatal diseases
Eloisa Gitto1, Lucia Marseglia1, Sara Manti2
1Neonatal Intensive Care Unit, Department of Pediatrics, University of Messina, Via Consolare Valeria, 98125 Messina, Italy.
Insights
Melatonin shows promise in reducing oxidative stress in newborns, potentially preventing or lessening conditions like chronic lung disease and brain injury. Further research is needed to confirm these benefits for neonatal health.
Area of Science:
- Neonatal medicine
- Pediatric oxidative stress research
- Antioxidant therapy
Background:
- Oxidative stress significantly worsens newborn conditions, termed "oxygen radical diseases of neonatology."
- Current strategies to boost antioxidant status in infants yield mixed results.
- Neonates exhibit unique susceptibility to oxidative damage.
Purpose of the Study:
- To evaluate the efficacy of melatonin in counteracting oxidative damage in newborns.
- To explore melatonin's potential role in preventing or reducing oxidative stress-related neonatal diseases.
Main Methods:
- Review of studies investigating melatonin's effects on neonatal oxidative stress.
- Analysis of melatonin's impact on specific newborn conditions: chronic lung disease, perinatal brain injury, necrotizing enterocolitis, and retinopathy of prematurity.
Main Results:
- Studies indicate promising results for melatonin in mitigating oxidative damage in various neonatal diseases.
- Melatonin has demonstrated potential benefits in treating conditions like chronic lung disease and perinatal brain injury.
Conclusions:
- Melatonin's antioxidant properties suggest a potential prophylactic role in preventing neonatal oxidative stress-related diseases.
- Further clinical studies are essential to validate the beneficial effects of melatonin in newborn populations.
Abstract:
Oxidative stress contributes to the severity of several newborn conditions to the extent that Saugstad coined the phrase "oxygen radical diseases of neonatology." In order to counteract free radicals damage many strategies to augment antioxidant status in ill-term and preterm infants have been proposed and several medications have been experimented with mixed results. Several studies have tested the efficacy of melatonin to counteract oxidative damage in diseases of newborns such as chronic lung disease, perinatal brain injury, necrotizing enterocolitis, and retinopathy of prematurity, giving promising results. The peculiar perinatal susceptibility to oxidative stress indicates that prophylactic use of antioxidants as melatonin could help to prevent or at least reduce oxidative stress related diseases in newborns. However, more studies are needed to confirm these beneficial effects.
Related Concept Videos
Management of Insomnia
The Pineal Gland
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Nightmares and Night Terrors
Nightmares...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

